BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

6:36 PM
 | 
Jun 05, 2008
 |  BC Extra  |  Company News

Transcription Factor receives rights to NF-kappa B program

Anesiva (NASDAQ:ANSV) granted Transcription Factor Therapeutics (Irvine, Calif.) exclusive worldwide rights to its NF-kappa B decoy program,...

Read the full 72 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >